DEVICES AND METHODS FOR SELECTIVELY LYSING CELLS
A system comprising: a container containing a measured amount of a solution including at least one of a vasoconstrictor, a surfactant, and an anesthetic, the solution comprising a liquid and at least one of a gas and a fluid; a needle array in fluid connection with the container, the needle array including at least one needle.
1 . A system comprising:
a container containing a measured amount of a solution including at least one of a vasoconstrictor, a surfactant, and an anesthetic, said solution comprising a liquid and at least one of a gas and a fluid;
a needle array in fluid connection with said container, said needle array including at least one needle.
2 . The system according to claim 1 , wherein the gas is at least partially dissolved in said fluid.
3 . The system of claim 1 , wherein the gas is fully dissolved in said liquid.
4 . The system according to claim 3 , wherein the container is enclosed, and the solution is maintained at greater than atmospheric pressure.
5 . The system of claim 1 , said at least one needle includes a lumen having a textured surface promoting the generation of microbubbles.
6 . The system according to claim 2 , wherein the gas comprises at least one gas selected from the group (air, oxygen, carbon dioxide, carbon dioxide, perfluoropropane, argon, hydrogen, Halothane, Desflurane, Sevoflurane, Isoflurane, and Enflurane).
7 . The system according to claim 1 , wherein the vasoconstrictor includes at least one of Norepinephrine, Epinephrine, Angiotensin II, Vasopressin and Endothelin.
8 . The system according to claim 1 , further comprising refrigeration means for maintaining the container at a predefined temperature range.
9 . The system according to claim 1 , wherein said container is thermally insulated.
10 . The system according to claim 3 , further comprising:
an ultrasound transducer apparatus capable of operating in at least one of first, second, third, and fourth energy settings,
wherein said first energy setting is selected to facilitate the absorption of solution by the tissue, said second energy setting is selected to facilitate stable cavitation, said third energy setting is selected to facilitate transient cavitation, and said fourth frequency range is selected to facilitate pushing bubbles within tissue.
11 . The system of claim 10 , wherein the transducer apparatus includes at least first and second transducers, wherein said first transducer facilitates popping of bubbles and said second transducer facilitates bringing dissolved gas out of solution.
3 . The system of claim 11 , wherein the first transducer surrounds the second transducer.
4 . The system of claim 11 , wherein the second transducer surrounds the first transducer.
5 . The system of claim 11 , wherein said transducer apparatus produces at least one of unfocussed and defocused ultrasound waves.
6 . The system of claim 11 , wherein said transducer apparatus selectively produces nonfocused ultrasound waves is a first mode and defocused ultrasound waves in a second mode.
7 . The system of claim 11 , wherein said first transducer has a generally planar acoustic wear layer and said second transducer has a convex acoustic wear layer.
8 . The system of claim 10 , wherein the transducer apparatus includes an array of first and second transducers, wherein said array of first transducers facilitates transient cavitation and than said array of second transducers facilitates bringing dissolved gas out of solution.
9 . The system according to claim 10 which the transducer apparatus is operably connected to the needle array.
10 . The system according to claim 1 wherein the container is a cartridge containing a predetermined amount of solution.
11 . A system comprising:
a container;
an aqueous solution in said container, said solution including epinephrine;
a needle array in fluid connection with said container and configured to percutaneously inject the solution into subcutaneous tissue, said needle array including at least one needle;
an ultrasound transducer apparatus capable of delivering ultrasound energy to the subcutaneous tissue at a frequency range selected to facilitate the absorption and/or uptake of solution by the tissue.
12 . The system of claim 11 , wherein said aqueous solution includes saline.
13 . The system of claim 11 , wherein the solution includes buffered saline.
14 . The system of claim 11 , wherein the solution includes buffered isotonic saline.
15 . A method for selectively lysing cells, comprising:
percutaneously injecting a solution including at least one of a vasoconstrictor, a surfactant, and an anesthetic into subcutaneous tissue,
insonating the tissue with ultrasound setting to distribute the solution by acoustic radiation force;
insonating the tissue at a second ultrasound setting to induce cell uptake of the solution.
16 . A method for selectively lysing cells, comprising:
percutaneously injecting a microbubble solution into subcutaneous tissue;
insonating the tissue at a first ultrasound setting to distribute the solution and push the microbubble against walls of the cells by acoustic radiation force;
insonating the tissue at a second ultrasound setting to induce transient cavitation.
17 . The method of claim 16 , wherein the solution includes at least one of a vasoconstrictor, a surfactant, and an anesthetic.
18 . A method for selectively lysing cells, comprising:
percutaneously injecting a solution into subcutaneous tissue, said solution containing at least one of a dissolved gas and a partially dissolved gas;
insonating the tissue to induce stable cavitation and generate microbubbles;
insonating the tissue with ultrasound to distribute the solution and push the microbubble against walls of the cells by acoustic radiation force;
insonating the tissue with ultrasound to induce transient cavitation.
19 . The method of claim 18 , wherein the solution includes at least one of a vasoconstrictor, a surfactant, and an anesthetic.